Mini Review
Published on 25 Jul 2018
Rationale for Combining Bispecific T Cell Activating Antibodies With Checkpoint Blockade for Cancer Therapy
in Pharmacology of Anti-Cancer Drugs
- 22,411 views
- 82 citations
Mini Review
Published on 25 Jul 2018
in Pharmacology of Anti-Cancer Drugs
Case Report
Published on 24 Jul 2018
in Pharmacology of Anti-Cancer Drugs
Review
Published on 06 Jul 2018
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 04 Jul 2018
in Pharmacology of Anti-Cancer Drugs
Case Report
Published on 05 Jun 2018
in Pharmacology of Anti-Cancer Drugs
Review
Published on 18 May 2018
in Pharmacology of Anti-Cancer Drugs
Review
Published on 18 May 2018
in Pharmacology of Anti-Cancer Drugs
Review
Published on 22 Mar 2018
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 11 Dec 2017
in Pharmacology of Anti-Cancer Drugs
General Commentary
Published on 21 Nov 2017
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 27 Jun 2017
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 10 Jan 2017
in Pharmacology of Anti-Cancer Drugs
Case Report
Published on 07 Oct 2016
in Pharmacology of Anti-Cancer Drugs
Review
Published on 10 May 2016
in Pharmacology of Anti-Cancer Drugs
Original Research
Published on 05 Jan 2016
in Pharmacology of Anti-Cancer Drugs
Editorial
Published on 11 May 2015
in Pharmacology of Anti-Cancer Drugs